Pricing Log in Create free account

Agios Pharmaceuticals, Inc. (AGIO) vs Vera Therapeutics, Inc. (VERA)

Agios Pharmaceuticals, Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Vera Therapeutics, Inc. are of similar size ($2.1B and $1.9B). Vera Therapeutics, Inc. has the higher net margin (0.00% vs −418.2%) and the higher return on invested capital (0.00% vs −70.2%). Across the 14 metrics below, Vera Therapeutics, Inc. leads on 8 and Agios Pharmaceuticals, Inc. on 6.

Valuation

Metric AGIO VERA Biotechnology median
P/E n/m n/m 8.50
P/S 18.95 n/m 9.71
P/B 1.82 4.91 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 12.67 n/m 9.21
Earnings yield (22.38%) (21.02%) (33.15%)
Free cash flow yield (19.60%) (16.92%) (25.50%)

Profitability

Metric AGIO VERA Biotechnology median
Gross margin 91.99% 0.00% 65.16%
Operating margin (466.78%) 0.00% 0.00%
Net margin (418.24%) 0.00% 0.00%
Free cash flow margin (371.43%) 0.00% 0.00%
Return on equity (34.34%) (91.75%) (56.36%)
Return on assets (31.89%) (72.32%) (48.04%)
Return on invested capital (70.24%) 0.00% 0.00%

Growth

Metric AGIO VERA Biotechnology median
Revenue growth (TTM) 140.58% — 6.02%
EPS growth (last fiscal year) (161.17%) (69.45%) 30.26%
Revenue growth, 5-year CAGR (14.45%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AGIO VERA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 10.22 10.92 4.72
Net debt to EBITDA 1.80 2.00 0.96

Dividend

Metric AGIO VERA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AGIO VERA Biotechnology median
Market cap 1.93b 2.06b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack